ArticleiScience2026
Machine learning models for early mortality prediction in severe fever with thrombocytopenia syndrome.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is a high-fatality viral disease where early mortality risk prediction is vital for clinical management. This retrospective multicenter cohort study enrolled 1,690 hospitalized SFTS patients from five Chinese hospitals (2014-2023) to develop, validate, and deploy an interpretable machine learning (ML) model for early mortality risk assessment. Using LASSO regression for feature selection then comparing eight ML algorithms, the XGBoost model achieved an AUC of 0.916 in the training cohort and 0.905 in the temporal validation cohort. SHapley Additive exPlanations (SHAP) analysis identified six key predictors, which were used to deploy a real-time, open-access web-based tool (https://sftsprognosis.com) that provides individualized risk predictions with visual explanations. The XGBoost model has the potential to enhance timely clinical decision-making, facilitate efficient allocation of critical care resources, and provide a generalizable framework for applying machine learning in the management of emerging infectious diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.